Karmen Stankov
Full Professor
Faculty of Medicine, Department of Biochemistry
karmen.stankov@mf.uns.ac.rs
Phone: 0216622907
ORCID ID : 0000-0002-3888-3473
Faculty of Medicine, Department of Biochemistry
karmen.stankov@mf.uns.ac.rs
Phone: 0216622907
ORCID ID : 0000-0002-3888-3473
| Academic career | Year | Institution | Field |
|---|---|---|---|
Status Acquired |
2017 |
Faculty of Medicine Novi Sad |
Biochemistry | Subspecialization |
2015 |
Faculty of Medicine Novi Sad |
Clinical Genetics |
Specialization |
2014 |
Faculty of Medicine Novi Sad |
Clinical Pharmacology |
PhD |
2004 |
Faculty of Medicine Novi Sad |
Biochemistry and Molecular Biology |
MSc |
2000 |
Faculty of Medicine Novi Sad |
Biochemistry and Molecular Biology |
Graduated |
1996 |
Faculty of Medicine Novi Sad |
General Medicine |
| M | Description |
|---|---|
42 | Монографија: Станков К. Генетске и молекуларне карактеристике карцинома штитасте жлезде са ћелијском оксифилијом. Медицински факултет Нови Сад, 2006, 172 стр. ISBN 86-7197-236-4 |
- | Уџбеник: Станков К. Биохемија и генетика наследних болести. Медицински факултет Нови Сад, 2016. ISBN: 978-86-7197-480-6 |
- | Практикум: Ковачевић З, Станков К, Бајин-Катић К. Приручник практичних и семинарских вежби из биохемије и молекуларне биологије. 2006. ISBN 86-7197-259-3 |
- | Поглавље у уџбенику: Станков К. Генетска предиспозиција за настанак малигнитета. Онкологија, уредник Дарјана Јовановић, Медицински факултет Нови Сад, 2009. ISBN 978-86-7197-292-5 |
21а | Stankov K, Benc D, Draskovic D. Genetic and epigenetic factors in etiology of diabetes mellitus type 1. Pediatrics. 2013; 32:1112-22 (IF=5.297, 2/118) |
21 | Stankov K, Stankov S, Katanić J. Genetic and epigenetic drug targets in myelodysplastic syndromes. Curr Pharm Des. 2017;23:135-69. (IF = 3.052, 74/25) |
21 | Stankov K. Editorial: Discovery and Validation of Drug Targets Through Human Genetics and Epigenetics. Curr Pharm Des. 2017;23:3-4. (IF = 3.052, 74/255) |
21 | Stankov K, Popovic S, Mikov M. C-kit signaling in cancer treatment. Curr Pharm Design, 2014; 20:2849-80 (IF = 3.452, 62/254) |
22 | Stankov K, Borisev I, Kojic V, Rutonjski L, Bogdanovic G. Modification of antioxidative and antiapoptotic genes expression in irradiated K562 cells upon fullerenol C60(OH)24 nanoparticle treatment. J Nanosci Nanotech. 2013;13:105-13 (IF = 1.339) |
21 | Stankov K, Pastore A, Toschi L, Kraimps JL, Bonneau D, Gibelin H, Levillain P, Volante M, Papotti M, Romeo G. Allelic loss on chromosomes 2q21 and 19p13.2 in Hürthle thyroid tumors. Intl J Cancer, 2004;111:463-7 (IF=4.416, 23/121) |
| Course | Studies |
|---|---|
Medical biochemistry and chemistry | Integrated academic studies in medicine |
General biochemistry | Integrated academic studies in pharmacy |
Medical biochemistry | Integrated academic studies in pharmacy |
Clinical biochemistry | Integrated academic studies in pharmacy |
Biochemistry | Integrated academic studies in dentistry |
Nanostructured biomaterials in dentistry | Integrated academic studies in dentistry |
Molecular human genetics | Doctoral academic studies - Preclinical research |
Molecular basis of inherited diseases | Doctoral academic studies - Preclinical research |
Actualities in Medical biochemistry | Doctoral academic studies - Preclinical research |
Actualities in Internal medicine | Doctoral academic studies - Clinical research |
Actualities in Medical biochemistry | Doctoral academic studies - Clinical research |
Molecular diagnostics and therapy of malignant diseases | Doctoral academic studies - Clinical research |